TrialLung cancer (Amsterdam, Netherlands)2012

Vatalanib in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (CALGB 30107).

Thierry Jahan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.